Patent application number | Description | Published |
20090018346 | Amorphous Form Of Darifenacin Hydrobromide And Processes For The Preparation Thereof - The present invention relates to amorphous form darifenacin hydrobromide and processes therefor. In addition, the present invention relates to compositions comprising amorphous form darifenacin hydrobromide. | 01-15-2009 |
20090093645 | SYNTHESIS AND PREPARATIONS OF DULOXETINE SALTS - The invention relates to an improved process for the preparation of duloxetine hydrochloride. | 04-09-2009 |
20090221668 | SYNTHESIS AND PREPARATIONS OF DULOXETINE SALTS - The invention relates to an improved process for preparing duloxetine hydrochloride. More particularly, the invention relates to the preparation of duloxetine hydrochloride by a process that provides a maximum yield of desired product with a minimum amount of undesired by-products. | 09-03-2009 |
20100069637 | CRYSTALLINE SALT FORMS OF A 5,6,7,8-TETRAHYDRO-1,2,4-TRIAZOLO[4,3-a]PYRAZINE DERIVATIVE - This invention provides novel crystalline acid salt forms of 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine, i.e. sitagliptin, to processes for their preparation and isolation, and to pharmaceutical compositions comprising the same. | 03-18-2010 |
20100286410 | Polymorphic Forms Of A 3-Pyrrole Substituted 2-Indolinone - The invention relates to new crystalline polymorphic forms of N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidine)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (i.e., sunitinib base), including Form I, Form II, and Form IV, processes for preparing crystalline polymorphic forms of sunitinib base, and pharmaceutically acceptable salts of new crystalline polymorphic forms of sunitinib base and pharmaceutical compositions comprising new crystalline polymorphic forms of sunitinib base, salts of new crystalline polymorphic forms of sunitinib base and mixtures thereof. | 11-11-2010 |
20100286412 | SYNTHESIS AND PREPARATIONS OF DULOXETINE SALTS - The invention relates to an improved process for the preparation of duloxetine, duloxetine intermediates, and duloxetine hydrochloride. | 11-11-2010 |
20110105750 | Salts of a Pyrazino[2,3-h][3]Benzazepine Derivative - This invention provides novel dicarboxylic acid salt forms of varenicline, wherein the acid is selected from maleic acid, fumaric acid, adipic acid, galactaric acid and malic acid. This invention provides also a carboxylic acid salt form of varenicline, wherein the acid is S-2-pyrrolidinon-5-carboxylic acid. This invention also provides methods for making these salt forms. | 05-05-2011 |
20110105788 | Polymorphic Form of an Aminoindan Mesylate Derivative - The invention relates to a polymorphic form of rasagiline mesylate, and to processes for preparing the same. | 05-05-2011 |
20120184558 | Crystalline Salt Forms of a 5,6,7,8-Tetrahydro-1,2,4-Triazolo[4,3-a]Pyrazine Derivative - This invention provides novel crystalline acid salt forms of 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine, i.e. sitagliptin, to processes for their preparation and isolation, and to pharmaceutical compositions comprising the same. | 07-19-2012 |